INTECH Investment Management’s Axsome Therapeutics AXSM Stock Holding History

INTECH Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Sell	1,375 -8,544	-86%	-$1.85M	﹤0.01%	1523
2026 Q1	$1.68M	Sell	9,919 -4,509	-31%	-$779K	0.02%	778
2025 Q4	$2.64M	Sell	14,428 -1,621	-10%	-$226K	0.02%	615
2025 Q3	$1.95M	Sell	16,049 -6,907	-30%	-$778K	0.02%	792
2025 Q2	$2.4M	Buy	22,956 +2,658	+13%	+$281K	0.02%	654
2025 Q1	$2.37M	Buy	20,298 +4,270	+27%	+$486K	0.02%	668
2024 Q4	$1.36M	Buy	16,028 +5,087	+46%	+$468K	0.01%	945
2024 Q3	$983K	Buy	+10,941	New	+$955K	0.01%	813

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

INTECH Investment Management's AXSM Position: Q2 2026 in Review

INTECH Investment Management reduced its Axsome Therapeutics (AXSM) stake by 86% in Q2 2026, selling an estimated $1.85M and leaving 1,375 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

INTECH Investment Management first reported a position in AXSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.64M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

INTECH Investment Management held 1,375 shares of Axsome Therapeutics worth $337K as of Q2 2026.
INTECH Investment Management sold 8,544 Axsome Therapeutics shares in Q2 2026, an estimated $1.85M.
Axsome Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1523 holding.
INTECH Investment Management first reported a position in Axsome Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Axsome Therapeutics position peaked at $2.64M in Q4 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.